The success of Mankind Pharma’s Rs 4,326-crore IPO, the biggest this year and the third-largest since 2022, augurs well for the moribund public issue market, which has seen just six issues this year. Mankind Pharma IPO was massively oversubscribed, at 15.3 times, at close yesterday. The portion for qualified institutional buyers was subscribed 49.16 times, […]
